RE:HME news - Cost OUT OF CONTROL - VMD immune?It is abvious that VMD is not immune to rising costs out pacing revenue, as they have no control to pass on those cost to the customer due to regulated pricing by the Gov't and insurance companies. The only reason for the S/P increase lately is because they bought $7mil of their own stock with small float/volume. Watch out when the buy back ends. IMO
Also, they will need monwy for aquisitions. The markets expects, small caps like VMD to have significant growth with rising margins, not just 20% per year and net income reveral. Thjus the aquisitions hires and new direction. IMO
GLTA